254 related articles for article (PubMed ID: 21951517)
1. Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection.
Lee J; Romero R; Xu Y; Kim JS; Park JY; Kusanovic JP; Chaiworapongsa T; Hassan SS; Kim CJ
Am J Reprod Immunol; 2011 Dec; 66(6):510-26. PubMed ID: 21951517
[TBL] [Abstract][Full Text] [Related]
2. Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.
Lee J; Romero R; Xu Y; Miranda J; Yoo W; Chaemsaithong P; Kusanovic JP; Chaiworapongsa T; Tarca AL; Korzeniewski SJ; Hassan SS; Than NG; Yoon BH; Kim CJ
Am J Reprod Immunol; 2013 Aug; 70(2):162-75. PubMed ID: 23841577
[TBL] [Abstract][Full Text] [Related]
3. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d.
Lee J; Romero R; Xu Y; Kim JS; Topping V; Yoo W; Kusanovic JP; Chaiworapongsa T; Hassan SS; Yoon BH; Kim CJ
PLoS One; 2011 Feb; 6(2):e16806. PubMed ID: 21326865
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the fetal blood transcriptome and proteome in maternal anti-fetal rejection: evidence of a distinct and novel type of human fetal systemic inflammatory response.
Lee J; Romero R; Chaiworapongsa T; Dong Z; Tarca AL; Xu Y; Chiang PJ; Kusanovic JP; Hassan SS; Yeo L; Yoon BH; Than NG; Kim CJ
Am J Reprod Immunol; 2013 Oct; 70(4):265-84. PubMed ID: 23905683
[TBL] [Abstract][Full Text] [Related]
5. Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies.
Lee J; Romero R; Dong Z; Xu Y; Qureshi F; Jacques S; Yoo W; Chaiworapongsa T; Mittal P; Hassan SS; Kim CJ
Histopathology; 2011 Nov; 59(5):928-38. PubMed ID: 22092404
[TBL] [Abstract][Full Text] [Related]
6. Correlation of ELISA-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection.
Kerman RH; Susskind B; Buelow R; Regan J; Pouletty P; Williams J; Gerolami K; Kerman DH; Katz SM; Van Buren CT; Kahan BD
Transplantation; 1996 Jul; 62(2):201-5. PubMed ID: 8755816
[TBL] [Abstract][Full Text] [Related]
7. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation.
Müller-Steinhardt M; Fricke L; Kirchner H; Hoyer J; Klüter H
Clin Transplant; 2000 Feb; 14(1):85-9. PubMed ID: 10693642
[TBL] [Abstract][Full Text] [Related]
9. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
10. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation.
Itescu S; Tung TC; Burke EM; Weinberg A; Moazami N; Artrip JH; Suciu-Foca N; Rose EA; Oz MC; Michler RE
Circulation; 1998 Aug; 98(8):786-93. PubMed ID: 9727549
[TBL] [Abstract][Full Text] [Related]
11. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.
Pagani FD; Dyke DB; Wright S; Cody R; Aaronson KD
J Heart Lung Transplant; 2001 Jun; 20(6):646-53. PubMed ID: 11404170
[TBL] [Abstract][Full Text] [Related]
12. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
13. HLA class I and class II antibodies: monitoring before and after kidney transplantation and their clinical relevance.
Schönemann C; Groth J; Leverenz S; May G
Transplantation; 1998 Jun; 65(11):1519-23. PubMed ID: 9645818
[TBL] [Abstract][Full Text] [Related]
14. Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection?
Romero R; Whitten A; Korzeniewski SJ; Than NG; Chaemsaithong P; Miranda J; Dong Z; Hassan SS; Chaiworapongsa T
Am J Reprod Immunol; 2013 Oct; 70(4):285-98. PubMed ID: 23905710
[TBL] [Abstract][Full Text] [Related]
15. Detection of HLA class I and II antibodies by ELISA and complement-dependent cytotoxicity before and after transplantation.
Christiaans MH; Nieman F; van Hooff JP; van den Berg-Loonen EM
Transplantation; 2000 Mar; 69(5):917-27. PubMed ID: 10755551
[TBL] [Abstract][Full Text] [Related]
16. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
[TBL] [Abstract][Full Text] [Related]
17. Association Between HLA Antibodies and Different Sensitization Events in Renal Transplant Candidates.
Akgul SU; Ciftci HS; Temurhan S; Caliskan Y; Bayraktar A; Tefik T; Kaya IA; Canitez IO; Demir E; Yazici H; Bakkaloglu H; Aydin AE; Turkmen A; Nane I; Aydin F; Oguz FS
Transplant Proc; 2017 Apr; 49(3):425-429. PubMed ID: 28340805
[TBL] [Abstract][Full Text] [Related]
18. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection.
Maymon E; Romero R; Bhatti G; Chaemsaithong P; Gomez-Lopez N; Panaitescu B; Chaiyasit N; Pacora P; Dong Z; Hassan SS; Erez O
J Perinat Med; 2018 Feb; 46(2):123-137. PubMed ID: 28829757
[TBL] [Abstract][Full Text] [Related]
20. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
Harmer AW; Heads AJ; Vaughn RW
Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
